Indian pharma, healthcare sector saw 55 deals worth $4.1 billion in Q2 2024
New Delhi: The Indian pharma and healthcare sector witnessed significant activity in the April-June quarter (Q2) this year with 55 deals totalling $4.1 billion, marking an 8 times increase in values and a 10 per cent rise in volumes over the previous quarter, a report showed on Tuesday. The average deal size surged from $9.7